Pfizer Limited (NSE:PFIZER)
5,016.90
+16.70 (0.33%)
At close: Dec 15, 2025
Pfizer Market Cap
Pfizer has a market cap or net worth of 229.51 billion as of December 15, 2025. Its market cap has decreased by -4.69% in one year.
Market Cap
229.51B
Enterprise Value
203.37B
Revenue
23.75B
Ranking
n/a
PE Ratio
27.34
Stock Price
5,016.90
Market Cap Chart
Since March 12, 1999, Pfizer's market cap has increased from 33.02B to 229.51B, an increase of 595.16%. That is a compound annual growth rate of 7.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 12, 2025 | 228.75B | -5.33% |
| Dec 31, 2024 | 241.62B | 23.72% |
| Dec 29, 2023 | 195.29B | -3.67% |
| Dec 30, 2022 | 202.74B | -12.34% |
| Dec 31, 2021 | 231.27B | -1.01% |
| Dec 31, 2020 | 233.62B | 20.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.30T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 934.94B |
| Mankind Pharma | 899.42B |
| Aurobindo Pharma | 694.12B |
| Alkem Laboratories | 673.27B |